These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 18039498)
1. Effects of angiotensin-converting enzyme inhibitors (ACE i) on zinc metabolism in patients with heart failure. Trasobares E; Corbatón A; González-Estecha M; Lopez-Colón JL; Prats P; Olivan P; Sánchez JA; Arroyo M J Trace Elem Med Biol; 2007; 21 Suppl 1():53-5. PubMed ID: 18039498 [TBL] [Abstract][Full Text] [Related]
2. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome. Gotsman I; Rubonivich S; Azaz-Livshits T Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235 [TBL] [Abstract][Full Text] [Related]
3. Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. Zuccalà G; Onder G; Marzetti E; Monaco MR; Cesari M; Cocchi A; Carbonin P; Bernabei R; Eur Heart J; 2005 Feb; 26(3):226-33. PubMed ID: 15618043 [TBL] [Abstract][Full Text] [Related]
4. Zinc nutrition in healthy subjects and patients with taste impairment from the view point of zinc ingestion, serum zinc concentration and angiotensin converting enzyme activity. Ueda C; Takaoka T; Sarukura N; Matsuda K; Kitamura Y; Toda N; Tanaka T; Yamamoto S; Takeda N Auris Nasus Larynx; 2006 Sep; 33(3):283-8. PubMed ID: 16530365 [TBL] [Abstract][Full Text] [Related]
5. Serum and urinary magnesium during treatment of patients with chronic congestive heart failure. Oladapo OO; Falase AO Afr J Med Med Sci; 2000; 29(3-4):301-3. PubMed ID: 11714011 [TBL] [Abstract][Full Text] [Related]
6. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials. Saha SA; Molnar J; Arora RR Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949 [TBL] [Abstract][Full Text] [Related]
7. [Rapid decrease of serum endothelin-1 levels after treatment with ACE inhibitors in chronic cardiac failure]. Ferrari E; Drai E; Jambou D; Talbodec A; Morand P; Baudouy M Arch Mal Coeur Vaiss; 1998 Jan; 91(1):53-7. PubMed ID: 9749264 [TBL] [Abstract][Full Text] [Related]
8. Comparison of high- versus low-tissue affinity ACE-inhibitor treatment on circulating aldosterone levels in patients with chronic heart failure. Vittorio TJ; Ahuja K; Kasper M; Turalic H; Tseng CH; Jorde UP; Go C J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):200-4. PubMed ID: 18205099 [TBL] [Abstract][Full Text] [Related]
9. Managing congestive heart failure in a general hospital in Malaysia. Are we keeping pace with evidence? Chin SP; Sapari S; How SH; Sim KH Med J Malaysia; 2006 Aug; 61(3):278-83. PubMed ID: 17240575 [TBL] [Abstract][Full Text] [Related]
10. [Patients with heart failure should primarily be treated with ACE inhibitors]. Johansson M Lakartidningen; 2004 Apr; 101(17):1536; discussion 1537-8. PubMed ID: 15150959 [No Abstract] [Full Text] [Related]
11. [Angiotensin converting enzyme inhibitors in the treatment of heart failure]. Bettencourt P; Ferreira A Rev Port Cardiol; 2000 Dec; 19 Suppl 2():II51-6. PubMed ID: 11301911 [TBL] [Abstract][Full Text] [Related]
12. Underutilization of angiotensin converting enzyme inhibitors among heart failure patients. Lean QY; Shamsuddin N; Wan Ahmad WA Med J Malaysia; 2008 Aug; 63(3):216-21. PubMed ID: 19248693 [TBL] [Abstract][Full Text] [Related]
13. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure. Cohen N; Golik A; Dishi V; Zaidenstein R; Weissgarten J; Averbukh Z; Modai D Miner Electrolyte Metab; 1996; 22(4):248-52. PubMed ID: 8807629 [TBL] [Abstract][Full Text] [Related]
14. Serum zinc and angiotensin-converting enzyme levels in patients with lung cancer. Bakan N; Bakan E; Süerdem M; Yiğitoğlu MR Biofactors; 1988 Jul; 1(2):177-8. PubMed ID: 2855586 [TBL] [Abstract][Full Text] [Related]
15. Zinc deficiency in patients with idiopathic taste impairment with regard to angiotensin converting enzyme activity. Takeda N; Takaoka T; Ueda C; Toda N; Kalubi B; Yamamoto S Auris Nasus Larynx; 2004 Dec; 31(4):425-8. PubMed ID: 15571918 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibition for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism. Weigel R; Hohenstein A; Schlickum L; Weiss C; Schilling L Neurosurgery; 2007 Oct; 61(4):788-92; discussion 792-3. PubMed ID: 17986940 [TBL] [Abstract][Full Text] [Related]
17. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure. Kazi D; Deswal A Cardiol Clin; 2008 Feb; 26(1):1-14, v. PubMed ID: 18312901 [TBL] [Abstract][Full Text] [Related]
18. Grossly elevated serum angiotensin-converting enzyme activities are still suppressible with ACE inhibitor therapy. Witham MD; Hutcheon SD; Fraser CG; McMurdo ME; Struthers AD J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):138. PubMed ID: 12228857 [No Abstract] [Full Text] [Related]
19. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure. Tribouilloy C; Rusinaru D; Leborgne L; Peltier M; Massy Z; Slama M Am J Cardiol; 2008 Mar; 101(5):639-44. PubMed ID: 18308013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]